Health Care/Hospital

3DMakerpro Medical Debuts New Products at AEEDC Dubai 2024 Conference

DUBAI, UAE, Feb. 8, 2024 /PRNewswire/ -- 3DMakerpro Medical, a sub-brand from the 3D scanning technology pioneer 3DMakerpro, has unveiled four new products at the AEEDCDubai 2024 Conference, the world's largest annual scientific dental conference and exhibition, held fromFebruary 6-8, 2024.

2024-02-08 13:00 1413

First in Human Dosed in Clinical Trial of ZMA001 for Treatment of Pulmonary Arterial Hypertension (PAH)

INCHEON, South Korea, Feb. 7, 2024 /PRNewswire/ -- Zymedi announced today that the first in human dosage of ZMA001, a monoclonal antibody being developed as a first-in-class treatment for Pulmonary Arterial Hypertension (PAH) has been initiated. The placebo-controlled phase 1 trial designed to a...

2024-02-08 11:53 1308

Datasea Regains Compliance with NASDAQ Minimum Bid Price Requirement

BEIJING, Feb. 7, 2024 /PRNewswire/ -- Datasea Inc., (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada incorporated digital technology corporation engaged in innovative business segments for intelligent acoustics and 5G messaging technology inChina announced today that, on February 6, 2024, it ...

2024-02-07 22:15 3668

Complete Genomics and seqWell Announce Codevelopment Partnership at AGBT

Companies will work together to offer fast, cost-effective ultra-high-throughput library preparation workflows SAN JOSE, Calif. and BEVERLY, Mass., Feb. 7, 2024 /PRNewswire/ -- Complete Genomics, a life sciences company specializing in end-to-end DNA sequencin...

2024-02-07 22:00 1297

I-Mab Signs Agreement to Divest its Assets and Business Operations in China

* Agreement marks an important milestone to advance the Company's intent to become a U.S.-based biotech  * Agreement provides for a strategic focus in advancing I-Mab's potential of differentiated oncology clinical assets and builds shareholder value by streamlining the operating model, reduc...

2024-02-07 19:00 1204

GC Labs successfully concludes day2 of Medlab Middle East 2024

YONGIN, South Korea, Feb. 6, 2024 /PRNewswire/ -- GC Labs, a leading clinical laboratory inSouth Korea, announced that the company concluded day2 with a successful performance at the Medlab Middle East 2024. An image o...

2024-02-06 23:00 1374

At AGBT, Complete Genomics showcases expanded sequencing applications, talks from customers and collaborators on research powered by the DNBSEQ-T7 Sequencer

The genomic sequencing solutions provider also introduces Q40 sequencing quality, announces new DNBSEQ products SAN JOSE, Calif., Feb. 6, 2024 /PRNewswire/ -- Complete Genomics, a California-based life sciences company that provides novel, comprehensive sequen...

2024-02-06 22:00 1120

Amorepacific Announces Positive Research Results of Fermented Ginseng in Skin Lymphatic Activation

Reveals potential improvement in lymphatic activation and skin health through fermented ginseng ingredients SEOUL, South Korea, Feb. 6, 2024 /PRNewswire/ -- Amorepacific, in collaboration with the School of Mechanical Engineering at Korea University, has unveiled groundbreaking research demonstr...

2024-02-06 22:00 1323

Rokit Healthcare Scores High Marks in KOSDAQ Tech Listing Evaluation

SEOUL, South Korea, Feb. 5, 2024 /PRNewswire/ -- Rokit Healthcare, a trailblazer in AI-driven medical bioprinting technology, proudly announces its achievement of an AA rating in the KOSDAQ (Korea Securities Dealers Automated Quotations) technology listing evaluation. Garnering A grades from both...

2024-02-05 22:00 1233

Deep Sleep in 10 minutes: MOZA Launches the Sleepris Eye Massager to Induce Better Sleep and Reduce Stress

IRVINE, Calif. , Feb. 5, 2024 /PRNewswire/ -- MOZA Technology ("MOZA'' or "the Company"), a pioneer in mindfulness and relaxation technology, has launched Sleepris, the first smart eye massager designed for comfortable all-night wear. Designed to alleviate insomnia, prevent sleep loss and reduce ...

2024-02-05 22:00 1553

Genesis MedTech Completes Enrollment in its United States Early Feasibility Study Utilizing the J-Valve™ Transfemoral System for Patients with Severe Aortic Regurgitation

JC Medical reports milestone accomplishment with its TAVR device BURLINGAME, Calif., Feb. 5, 2024 /PRNewswire/ -- Genesis MedTech, a leading medical device company, today announced the completion of enrollment in its United States Early Feasibility Study (EFS) using its dedicated transcatheter ...

2024-02-05 22:00 1100

BrainGear Develops SleePYA, the Digital Healthcare for Brain Rehabilitation and Sleep Aid

SEOUL, South Korea, Feb. 5, 2024 /PRNewswire/ -- As startup engaging in digital healthcare business, especially brain rehabilitation and sleep aid, BrainGear has developed SleePYA with infrared light to stimulate the brain to induce quality of sleep.

2024-02-05 22:00 1194

Technoderma Medicines Phase 2 Clinical Trial of TDM-105795 Demonstrates Hair Growth in Androgenetic Alopecia

CHENGDU, China, Feb. 5, 2024 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report that the Company has completed its Phase 2a clinical trial (NCT05802173) of TDM-105795 topical solution for Androgenetic Alopecia (AGA). This ...

2024-02-05 21:00 1278

NouvNeu001 Achieves Milestone with Successful Dosing of First Patient, Signaling Smooth Progress in iRegene Therapeutics' Multicenter Clinical Trial for Innovative Novel Parkinson's Disease Therapy

WUHAN, China, Feb. 5, 2024 /PRNewswire/ -- iRegene Therapeutics Co., Ltd (iRegene) recently announced that NouvNeu001, the company's first innovative product, has completed the dosing for its first patient at Beijing Hospital, and the patient has also successfully concluded the observation period...

2024-02-05 21:00 1370

Wingderm® "Dual Innovation, Infinite Possibilities" Global Distributor conference was successfully held at IMCAS

BEIJING, Feb. 5, 2024 /PRNewswire/ -- IMCAS World Congress 2024 was held in Paris, France from February 1st to 3rd. On the first day, Wingderm® successfully held the "Dual Innovation, Infinite Possibilities" new device release conference for its signed distributors worldwide, along with Renuva® ...

2024-02-05 16:50 1051

Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE2016, a First-in-Class Allogeneic Anti-EGFR Cell Therapy

* ACE2016 Is an Allogeneic Gamma Delta 2 (γδ2) T Cell Therapy Targeting the Epidermal Growth Factor Receptor (EGFR) in Patients With Solid Tumors. * Phase 1 Clinical Study Expected to Begin in H2 2024. ALAMEDA, Calif. and TAIPEI, Feb. 4, 2024 /PRNewswire/ -- Acepodia (6976:TT), a clinical stag...

2024-02-05 08:00 1187

Blossoming Flowers at the Top of the Biopharmaceutical Tree -- Reflections on the Flourishing of Sanyou's 4C Business

SHANGHAI, Feb. 2, 2024 /PRNewswire/ -- In 1996, MDS Pharma Service invested in and established the first true Contract Research Organization (CRO) inChina, dedicated to clinical trial business for new drugs. This marked the official launch of the CRO industry inChina. The concept of CRO originat...

2024-02-03 08:00 2060

Inmagene Exercises Option to Obtain Exclusive Worldwide License for IMG-007 and IMG-004 from HUTCHMED

* Inmagene exercised its option under the previously announced collaboration agreement to obtain an exclusive, royalty-bearing license for IMG-007, an anti-OX40 monoclonal antibody (mAb) and IMG-004, a Bruton Tyrosine Kinase (BTK) inhibitor * Inmagene retains rights to develop and commerciali...

2024-02-02 22:00 1466

Wingderm® Launches Lasermach2, Revolutionizing Hair Removal Solution, at IMCAS World Congress 2024 in Paris

BEIJING, Feb. 2, 2024 /PRNewswire/ -- In the morning of February 1st, Wingderm® announced the launch of Lasermach2 at IMCAS World Congress 2024 in Paris, which represents another revolutionizing breakthrough by Wingderm® in medical aesthetics industry. Wingderm® founder and CEO, Will Wang, as th...

2024-02-02 17:00 1226

2024 Global Appeal Calls for Well-Informed Public to 'Break Chains of Discrimination' against Leprosy

TOKYO, Feb. 1, 2024 /PRNewswire/ -- Sasakawa Leprosy (Hansen's Disease) Initiative has partnered with the World Health Organization to co-host the launch of the 2024 Global Appeal to end stigma and discrimination against persons affected by leprosy at WHO headquarters inGeneva on January 31, 2024...

2024-02-01 14:00 1373
1 ... 6789101112 ... 252